Lifordi Immunotherapeutics, Inc.
PrivateLast Round
Series A
Extension
Nov 18, 2025
Total Funding Raised
$112M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lifordi Immunotherapeutics, Inc. is a biotechnology company that develops targeted antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lifordi Immunotherapeutics, Inc. Comparables
Compare Lifordi Immunotherapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santa Ana Bio | 79% | |
| AbbVie | 76% | |
| AbolerIS Pharma | 71% |
Lifordi Immunotherapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 18, 2025 |
Key People
Founding team and executive leadership
Lifordi Immunotherapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARCH Venture Partners | Series A, Series A Extension |
| 5AM Ventures | Series A, Series A Extension |
| Sanofi Ventures | Series A Extension |
| Atlas Venture | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 59% MoM, reaching 12.4K.
- Jan 24, 2026
Monthly visitors increased 1486% MoM, reaching 7.8K.
Lifordi Immunotherapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lifordi Immunotherapeutics, Inc.'s valuation, stock price, and market status.
Is Lifordi Immunotherapeutics, Inc. a public or private company?
Lifordi Immunotherapeutics, Inc. is a private company.
What is the current stock price of Lifordi Immunotherapeutics, Inc.?
Lifordi Immunotherapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Lifordi Immunotherapeutics, Inc. worth (valuation)?
Valuation information for Lifordi Immunotherapeutics, Inc. is not publicly available.
Can I buy Lifordi Immunotherapeutics, Inc. stock?
Lifordi Immunotherapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lifordi Immunotherapeutics, Inc.'s last funding round?
Lifordi Immunotherapeutics, Inc.'s most recent funding round was Series A Extension on November 18, 2025.
Who are the main investors in Lifordi Immunotherapeutics, Inc.?
Key investors in Lifordi Immunotherapeutics, Inc. include ARCH Venture Partners, 5AM Ventures, Sanofi Ventures, Atlas Venture.
Will Lifordi Immunotherapeutics, Inc. IPO soon?
No public IPO plans have been announced for Lifordi Immunotherapeutics, Inc..
How can I track Lifordi Immunotherapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lifordi Immunotherapeutics, Inc.'s secondary market activity and sign up for updates.